Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 132 (6), 860-868
- https://doi.org/10.1016/s0002-9394(01)01257-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAmerican Journal of Ophthalmology, 2001
- Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor AgonistJournal of Ocular Pharmacology and Therapeutics, 2001
- Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With GlaucomaJournal of Glaucoma, 2000
- Quantitative Autoradiographic Visualization and Pharmacology of FP-Prostaglandin Receptors in Human Eyes Using the Novel Phosphor-Imaging TechnologyJournal of Ocular Pharmacology and Therapeutics, 1999
- [3H]AL-5848 ([3H]9β-(+)-Fluprostenol). Carboxylic Acid of Travoprost (AL-6221), a Novel FP Prostaglandin o study the Pharmacology and Autoradiographic Localization of the FP ReceptorJournal of Pharmacy and Pharmacology, 1999
- Prostaglandin F2αand its Analogs Induce Release of Endogenous Prostaglandins in Iris and Ciliary Muscles Isolated from Cat and Other Mammalian SpeciesExperimental Eye Research, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Effects on Intraocular Pressure and Side Effects of 0.005% Latanoprost Applied Once Daily, Evening or MorningOphthalmology, 1995
- Association between intraocular pressure and loss of visual field in chronic simple glaucoma.British Journal of Ophthalmology, 1990
- Intraocular Pressure and GlaucomaAmerican Journal of Ophthalmology, 1989